News

Three U.S. infants born with birth defects linked to Zika virus


 

References

There have been three infants born with birth defects and three pregnancy losses as a result of likely maternal Zika virus infection among U.S. women, according to figures released by the Centers for Disease Control and Prevention.

The figures, posted by the CDC on June 16, reflect reporting to the U.S. Zika Pregnancy Registry as of June 9. This is not real-time data and reflects only pregnancy outcomes for women with any laboratory evidence of possible Zika virus infection, though it is not known if Zika virus was the cause of the poor outcomes. The numbers also do not reflect outcomes among ongoing pregnancies.

Zika-related birth defects recorded by the CDC could include microcephaly, calcium deposits in the brain indicating possible brain damage, excess fluid in the brain cavities and surrounding the brain, absent or poorly formed brain structures, abnormal eye development, or other problems resulting from brain damage that affect nerves, muscles, and bones. The pregnancy losses encompass any miscarriage, stillbirth, and termination with evidence of birth defects.

The current numbers include outcomes reported in U.S. states and the District of Columbia. The CDC will begin reporting outcomes in U.S. territories in the coming weeks.

CDC officials plan to update the pregnancy outcome data every Thursday at http://www.cdc.gov/zika/geo/pregnancy-outcomes.html.

mschneider@frontlinemedcom.com

On Twitter @maryellenny

Recommended Reading

When could use of antenatal corticosteroids in the late preterm birth period be beneficial?
MDedge ObGyn
Remote prenatal care monitoring is a hit with patients
MDedge ObGyn
2016 Update on infectious disease
MDedge ObGyn
Study helps set upper boundary for leukocytosis after prenatal corticosteroids
MDedge ObGyn
Postpartum glycemic screening rates are low for women with GDM history
MDedge ObGyn
Obesity in healthy women linked to poor pregnancy and neonatal outcomes
MDedge ObGyn
Cesarean delivery rates among nulliparous women are lower after guidance
MDedge ObGyn
A review of 2015 drug approvals: Safety in pregnancy and lactation
MDedge ObGyn
Tenofovir may prevent mother-to-child transmission of hepatitis B
MDedge ObGyn
Insomnia linked to increased risk of pregnancy loss
MDedge ObGyn